Why You Should Consider Investing In Biotechs and Why You Don’t

Why You Should Consider Investing In Biotechs and Why You Don’t

Akebia Therapeutics up 70% in the after hours is why you should consider buying biotechs and Tetraphase Pharmaceuticals down 79% is why many don’t.  Small-cap biotechs offer the biggest mispricing (opportunities) in the market; a promised land full of landmines.  A basket of biotechs and or the ETF’s (XBI, BBH) make more sense to me than a flyer with one.

fzorrilla@zorcapital.com   @Zortrades
#STOCKS 
By |2018-02-02T12:09:36+00:00September 8, 2015 7:08 pm|

About the Author:

Leave A Comment